Introduction
Functional human DNA mismatch repair (MMR) activity requires hMutSa (a heterodimer of hMSH2 and hMSH6) and hMutSb (a heterodimer of hMSH2 and hMSH3) to recognize and bind mispairs and/or insertion/deletion loops (IDLs) that occur at microsatellite sequences, and hMutLa (a heterodimer of hMLH1 and hPMS2) to help coordinate DNA repair (Acharya et al., 1996; Palombo et al., 1996) . More specifically, hMutSa recognizes single-nucleotide interstrand mispairs and IDLs containing one or two looped nucleotides, whereas hMutSb recognizes IDLs of X2 nucleotides (Modrich, 2006) . Subsequently, the hMutSa or hMutSb heterodimer interacts with the hMutLa complex to coordinate excision and repair of the mispair or IDL (Modrich, 2006) . Defects in DNA MMR cause microsatellite instability (MSI) due to the inability of the system to recognize or repair frameshifts at the microsatellites (Grady and Carethers, 2008) . Germline mutations of hMSH2, hMLH1, hMSH6 or hPMS2 cause Lynch syndrome, which has an 80% lifetime risk for colorectal cancer (CRC), and epigenetic inactivation of hMLH1 by promoter hypermethylation is observed in 15-20% of sporadic CRCs (Fishel et al., 1993; Nicolaides et al., 1994; Papadopoulos et al., 1994; Akiyama et al., 1997; Herman et al., 1998; Veigl et al., 1998) . CRCs from Lynch syndrome and sporadic hMLH1-defective cancer patients show the phenotype of MSI (Carethers, 1999; Grady and Carethers, 2008) .
Microsatellite sequences are predominantly located in the non-coding regions of the genome (Thibodeau et al., 1993) . However, some microsatellites are present in the exonic coding regions of genes, with accumulation of frameshift mutation within alleles of these genes deregulating normal cellular processes and driving the pathogenesis of CRC with MSI (Woerner et al., 2005; Jung et al., 2006 ). An A 10 microsatellite within the transforming growth factor b receptor 2 (TGFBR2) exon 3 and an A 8 microsatellite within ACVR2 exon 10 become -1 bp frameshift mutated at both alleles in 70-90% of CRC with MSI Hempen et al., 2003; Jung et al., 2004) . These frameshift mutations of TGFBR2 and ACVR2 cause loss of protein expression and their growth-suppressive effects that are mediated by intracellular SMAD signaling Jung et al., 2006) . Furthermore, we have measured the mutation rates of TGFBR2 exon 3 and ACVR2 exon 10 and shown that both accumulate frameshift mutations in hMLH1-defective and hMSH6-defective cells after forming heteroduplexes at a constant rate of formation (Chung et al., 2008) .
ACVR2 shows exonic selectivity for frameshift mutation. ACVR2 contains identical octoadenine tracts in exons 3 and 10, but only its exon 10 octoadenine tract is mutated in CRC with MSI (Hempen et al., 2003; Jung et al., 2004) . The cause for this selectivity is not known, although this is an important concept that potentially drives the pathogenesis of CRC and may determine what genes and coding microsatellites become mutated. The spectra of genes with coding microsatellites are broad but seem to favor tumor suppressors; however, the frequency for mutation of genes is varied in cancers, even when microsatellite lengths are identical. The two identical intragenic ACVR2 microsatellites afforded us an opportunity to accurately measure mutation rates, and also to manipulate the sequences surrounding the microsatellite to test the hypothesis that the primary DNA sequence influences microsatellite mutation. In yeast models, it was reported that the six nucleotides surrounding mispair influence mispair recognition by MMR proteins and may alter mutation rates (Marsischky and Kolodner, 1999) . To study this in a human model, we constructed enhanced green fluorescent protein (EGFP) plasmids in which a À1 bp frameshift mutation at the coding microsatellites of ACVR2 exons 10 and 3 could be detected by EGFP expression in MMR-deficient cells. We also swapped the DNA sequences surrounding exon 10 and 3 microsatellites of ACVR2 to determine whether this modifies frameshift mutation rates. Observed in real time, we show exonic selectivity of ACVR2 exon 10 for frameshift mutation over ACVR2 exon 3 with MMR deficiency, and further show that DNA sequences flanking the exon 3 and 10 microsatellites of ACVR2 alter frameshift mutation.
Results
Selectivity for frameshift mutation of ACVR2 exon 10 over ACVR2 exon 3, and dependence on the DNA MMR background To measure the exonic selectivity of ACVR2 for frameshift mutation, we used stable cell lines containing native ACVR2 exon 10 or 3 sequences within hMLH1
À/À and hMSH3 À/À backgrounds (Supplementary  Table S1 ). At 4 weeks after establishing stable cell lines, the proportion of fluorescent cells within each cell line was measured using flow cytometry. All mutationresistant (MR) ACVR2 in frame of EGFP (IF) cell lines showed fluorescence between 83 and 100% (median 96%), showing robust EGFP expressional selection efficiency. The hMLH1 À/À ACVR2 exon 10 and ACVR2 exon 3 þ 1 bp out of frame of EGFP (OF) cells, and hMSH6 À/À ACVR2 exon 10 OF cells revealed newly fluorescent cells ranging between 0.10 and 0.72% (median 0.13%) net fluorescence over counterpart MR Table S1 ), nonfluorescent cells (cells without baseline mutation) containing either MR ACVR2 exon 10 OF, ACVR2 exon 10 OF, MR ACVR2 exon 3 OF or ACVR2 exon 3 OF were sorted and exponentially grown for 7-28 days. EGFP flow cytometric histograms at day 21 are shown in Figure 1 . As we observed previously (Chung et al., 2008) , two distinct EGFP-expressing cell populations, M1 and M2, were revealed from hMLH1 À/À ACVR2 exon 10 OF cells. However, no significant proportion of the M2 population was observed in hMLH1 À/À ACVR2 exon 3 OF cells. In addition, hMSH6 À/À ACVR2 exon 3 OF cells revealed only an M1 population, whereas hMSH6 À/À ACVR2 exon 10 OF revealed both M1 and M2 populations. These findings indicate selectivity for ACVR2 exon 10 mutation in hMLH1 À/À and hMSH6
backgrounds, with lack of development of ACVR2 exon 3 mutation in the same MMR-deficient backgrounds. We performed sequencing analysis to confirm that fluorescence from the M1 and M2 populations was driven by À1 bp frameshift mutation. At day 21 after plating non-fluorescent cells, the M1 and/or M2 cell populations of MR ACVR2 exon 10 OF, ACVR2 exon 10 OF, MR ACVR2 exon 3 OF and ACVR2 exon 3 OF from different MMR-deficient backgrounds were sorted and expanded for sequencing analysis (Figure 2 ). The M2 populations of ACVR2 exon 10 OF cell lines in hMLH1 À/À and hMSH6 À/À backgrounds revealed only À1 bp frameshifted microsatellite sequence (A 7 ), indicating full mutant (A 7 /T 7 ) formation that induces bright EGFP expression as observed previously (Chung et al., 2008) . In comparison, the M1 populations of hMLH1 À/À ACVR2 exon 10 OF and ACVR2 exon 3 OF cells revealed overlapping sequences, with wild-type (WT) and mutant microsatellite sequences present, highly suggestive of heteroduplex (A 7 /T 8 ) formation that weakly drives EGFP expression (Chung et al., 2008) . The M1 cells from hMLH1 À/À ACVR2 exon 10 OF revealed a higher proportion of mutant sequence (the main peak is A 7 ) compared with hMLH1 À/À ACVR2 exon 3 OF M1 cells (the main peak is A 8 ; Figure 2 ). These data indicate that the M1 population of hMLH1 À/À ACVR2 exon 10 OF cells has a higher tendency for À1 bp frameshift mutation than hMLH1 À/À ACVR2 exon 3 OF cells and only hMLH1 À/À ACVR2 exon 10 OF cells complete the mutation process into an M2 population. The M1 population from hMSH6 À/À ACVR2 exon 10 OF cells revealed WT microsatellite sequence, although its M2 population revealed the mutant sequence, and suggested a lower tendency for heterodulpex formation in the hMSH6 À/À background when compared with the hMLH1 À/À background. As we observed previously (Chung et al., 2008) , the À1 bp mutation frequency of the M2 population from the ACVR2 Flanking sequence specificity for microsatellite mutation H Chung et al exon 10 sequence in the hMLH1 À/À background dramatically accumulated over time, whereas its M1 population showed little change over time (Figure 3 ), again indicating that M1 and M2 are distinct populations. In the M1 population, mutation frequency of hMLH1 À/À ACVR2 exon 10 cells was higher than other cell lines and increased over time (highest at day 28, 12-fold change), although the increase over time was small when compared with the increase in the M2 population (Figure 3a ). There was no consistent increase in the M1 population in other cell lines. Only the ACVR2 exon 10 sequence in hMLH1 À/À and hMSH6 À/À backgrounds revealed any prominent M2 population. In the M2 population, ACVR2 exon 10 sequence in the hMLH1 À/À background showed its highest mutation frequency over time (up to day 21, 143-fold change) as predicted by the EGFP histograms (Figure 1) , and mutation frequency of the ACVR2 exon 10 sequence in the hMSH6 À/À background also increased over time showing its highest mutation frequency on day 28 (5-fold change), although this frequency is much lower than ACVR2 exon 10 sequence in hMLH1 À/À cells (Figure 3b ). In hMLH1 À/À ACVR2 exon 3 cells, hMSH6
À/À ACVR2 exon 3 cells and all hMSH3 À/À cell lines, M2 cells were extremely rare events (average 0.002%) at all time points, with no significant difference in numbers of the M2 population between MR ACVR2 OF and ACVR2 OF cells, as shown in Figure 1 . Thus, the fold change in the M2 population of these cells was one at all time points (Figure 3b) .
The M2 population (full mutants) was used to calculate the mutation rates. The mutation rate of ACVR2 exon 10 microsatellite in hMLH1 deficiency was 1.61 Â 10 À4 ±0.49 Â 10 À4 . The mutation rate at the microsatellite of ACVR2 exon 10 in hMSH6 deficiency (0.15 Â 10 À4 ± 0.02 Â 10
À4
) is B10 times lower than one in hMLH1 deficiency. These mutation rates are comparable to ones determined previously (Chung et al., 2008) . Mutation rates from hMSH3 À/À ACVR2 exon 10 cells and all cell lines containing ACVR2 exon 3 sequences were not calculated because of a lack of M2 populations.
Overall, our data indicate that MMR-deficient backgrounds determine the mutation frequency and rate of the coding microsatellites of ACVR2 exons 10 and 3.
hMLH1 deficiency provides the highest susceptibility for frameshift mutation at the microsatellites of both exons 10 and 3 of ACVR2 among three different MMR deficiencies (hMLH1 À/À , hMSH6 À/À and hMSH3
). In addition, the microsatellite of ACVR2 exon 10 has a higher susceptibility to a À1 bp frameshift mutation than ACVR2 exon 3 in hMLH1 and hMSH6 deficiencies, showing exonic selectivity for a À1 bp frameshift mutation of ACVR2, which is observed in CRC with MSI.
Flanking (F) sequences of ACVR2 microsatellites modify heteroduplex formation and frameshift mutation rates in the hMLH1 À/À background To address the cause of exonic selectivity for a À1 bp frameshift mutation of ACVR2 in MMR deficiency, we hypothesized that the different mutation rates for each coding microsatellite of ACVR2 could be determined by Figure 1 Mutation analysis of cells containing native ACVR2 exons 10 or 3 sequences using flow cytometry. Non-fluorescent cells were sorted and exponentially grown for 7-28 days. At specific time points, cells were harvested, and 200 000 cells were analyzed for EGFP expression (identifying a À1 bp frameshift mutation) using flow cytometry. Gated live cells were analyzed on an EGFP histogram and two distinct EGFP populations were plotted. The population with dim EGFP expression was designated as M1 and the population with bright EGFP expression was designated as M2. EGFP histograms of MR ACVR2 exon 10 OF, ACVR2 exon 10 OF, MR ACVR2 exon 3 OF and ACVR2 exon 3 OF cells in different MMR deficient backgrounds at day 21 were shown as representatives of mutation analysis. Note that scaling of cell counts in each EGFP histogram is different.
Flanking sequence specificity for microsatellite mutation H Chung et al DNA sequences surrounding the microsatellite. To test this, stable cell lines containing substituted ACVR2 sequences (Table 1) , hMLH1 À/À MR ACVR2 exon 10-exon 3 F IF, ACVR2 exon 10-exon 3 F OF, MR ACVR2 exon 3-exon 10 F IF and ACVR2 exon 3-exon 10 F OF cells were generated. Previously generated hMLH1 À/À stable cell lines containing the native ACVR2 sequences (Supplementary Table S1 ) were used together for comparison of EGFP expression between native and substituted ACVR2 sequences.
To compare mutation frequencies and rates of cells containing native ACVR2 exon 10 and 3 sequences with ones of cells containing substituted ACVR2 exon 10 and 3 sequences in the hMLH1 À/À background, non-fluorescent cells containing either MR ACVR2 exon 10 OF, ACVR2 exon 10 OF, ACVR2 exon 10-exon 3 F OF, MR ACVR2 exon 3 OF, ACVR2 exon 3 OF or ACVR2 exon 3-exon 10 F OF were sorted and exponentially grown for 14-35 days. EGFP histograms at day 28 are shown in Figure 4 . Consistent with earlier results, in this independent experiment, hMLH1
À/À ACVR2 exon 3 OF cells revealed only the M1 population whereas hMLH1 À/À ACVR2 exon 10 OF cells revealed both M1 and M2 populations. The ACVR2 exon 10 microsatellite with exon 3 flanking sequences (ACVR2 exon 10-exon 3 F OF) showed a 2.6-fold less M1 and a 24-fold less M2 populations when compared with cells containing native ACVR2 exon 10 OF sequence. In comparison, cells containing ACVR2 exon 3-exon 10 F OF sequence had a 1.5-fold higher M1 population than the cells containing native ACVR2 exon 3 OF sequence. Furthermore, a new M2 population developed in cells containing ACVR2 exon 3-exon 10 F OF sequence that was completely absent in hMLH1 À/À ACVR2 exon 3 OF cells. These data indicate that the surrounding sequences of ACVR2 microsatellite alter -1 bp frameshift mutation frequencies in the hMLH1 deficiency.
The À1 bp mutation frequency at each time point is shown in Figure 5 . For the M1 population in this independent experiment, the mutation frequency for hMLH1 À/À ACVR2 exon 10 OF cells was higher than other cell lines at all time points and increased up to day 21 (28-fold) and then decreased ( Figure 5 ). This is consistent in pattern and extent with our earlier results. The M1 population of hMLH1 À/À ACVR2 exon 10-exon 3 F OF, ACVR2 exon 3-exon 10 F OF and ACVR2 exon 3 OF cells showed an B5-20 times less mutation frequency compared with hMLH1 À/À ACVR2 exon 10 OF cells, but showed steady-state stable increases in frequency over time. For the M2 population, hMLH1 À/À ACVR2 exon 10 OF cells showed the highest mutation frequency over time when compared with other cell lines, as predicted in EGFP histograms ( Figure 4 ). As observed previously (Chung et al., 2008) and in our earlier results, the M2 population in this independent experiment from hMLH1 À/À ACVR2 exon 10 OF cells accumulated over time. A significantly decreased mutation frequency (Po0.01) was observed in the M2 population of hMLH1 À/À ACVR2 exon 10-exon 3 F OF cells at all time points compared with hMLH1 À/À ACVR2 exon 10-OF cells ( Figure 5 ). hMLH1 À/À ACVR2 exon 3 cells did not reveal an M2 population, whereas hMLH1 À/À ACVR2 exon 3-exon 10 F OF cells revealed small proportions of an M2 population at day 28 (threefold change) and day 35 (fourfold change). However, there is no significant difference between the mutation frequencies of hMLH1 À/À ACVR2 exon 10-exon 3 F OF and hMLH1 À/À ACVR2 exon 3-exon 10 F OF cells at all time points.
To confirm that our EGFP expression experiments resulted in frameshifts, at day 21 after being plated as non-fluorescent cells the M1 and/or M2 cell populations of hMLH1 À/À MR ACVR2 exon 10 OF, ACVR2 exon 10 OF, ACVR2 exon 10-exon 3 F OF, MR ACVR2 exon 3 OF, ACVR2 exon 3 OF or ACVR2 exon 3-exon 10 F OF cells were sorted and expanded for sequencing analysis. Single cell clones were individually sequenced to assess for frameshift mutation. As expected, nearly all DNA clones (90-100%) from the M2 population of cell lines containing ACVR2 exon 10 OF or ACVR2 exon 10-exon 3 F OF revealed À1 bp frameshifts (A 7 ) (Table 2), indicating full mutant (A 7 /T 7 ) formation. Flanking sequence specificity for microsatellite mutation H Chung et al The M2 population of hMLH1 À/À ACVR2 exon 3-exon 10 F OF cells did not commence until day 28 after plating, and thus sequencing analysis for the M2 population of this cell line was not performed. On the other hand, DNA clones from the M1 population of hMLH1 À/À ACVR2 exon 10 OF and ACVR2 exon 10-exon 3 F OF revealed 74 and 55% of mutant microsatellite and 26 and 45% of WT microsatellite, respectively (Table 2) , indicating heteroduplex (A 8 /T 7 ) formation. Swapping the surrounding DNA sequences of the ACVR2 exon 10 microsatellite with ones surrounding the ACVR2 exon 3 microsatellite decreased the number of clones with mutant microsatellites from 74 to 55% for the M1 population. In comparison, DNA clones from the M1 population of hMLH1 À/À ACVR2 exon 3 OF and ACVR2 exon 3-exon 10 F OF cells increased from 47 to 90% of mutant microsatellites, respectively, indicating that the exon 10 flanking sequences allow a microsatellite to be more prone to mutation with DNA MMR deficiency ( Table 2) . These sequencing data show that the flanking sequences of ACVR2 microsatellite alter heteroduplex formation in the hMLH1 À/À background. As shown in Table 3 , the mutation rate for hMLH1 À/À ACVR2 exon 10 cells was 4.37 Â 10 À5 ±0.49 Â 10 À5 . The mutation rate for hMLH1 À/À ACVR2 exon 10-exon 3 F OF cells (0.67 Â 10 À5 ±0.37 Â 10 À5 ) is B6 times lower when compared with counterpart cells containing ACVR2 exon 10 OF sequence (Po0.001), indicating that the exon 3 flanking sequences make a microsatellite less prone to mutation with DNA MMR deficiency. The mutation rate from hMLH1 À/À ACVR2 exon 3 cells was 0.00 Â 10 À5 , as no M2 population developed over 35 days of observation. However, cells containing ACVR2 exon 3-exon 10 F OF sequence revealed a new M2 population at day 28, with a mutation rate of 0.93 Â 10 À5 ±0.51 Â 10 À5 . These data indicate that the surrounding sequences of ACVR2 microsatellites alter mutation rates of the two ACVR2 coding microsatellites in the hMLH1 -/-background.
Discussion
In this study, we hypothesized that the different frameshift mutation frequencies of the coding microsatellites of ACVR2 exons 10 and 3 in CRC with MSI are determined by DNA sequences flanking the microsatellites. To test this, we used stable human MMR cell lines in which we transfected ACVR2 exon 10 and 3 sequences linked out of frame to EGFP (Chung et al., 2008) , and these cell lines allowed us to observe À/À background showed the highest mutation frequency for both M1 and M2 populations accumulating over time. The M1 populations of ACVR2 exon 10 sequence in the different MMR-deficient backgrounds and the ACVR2 exon 3 sequence in all MMRdeficient backgrounds did not show any consistent increase in mutation frequency over time. The M2 population of ACVR2 exon 10 sequence in the hMSH6 À/À background had a slight increase in mutation frequency over time, although this frequency is much lower than one of ACVR2 exon 10 sequence in the hMLH1 À/À background. Cell lines showing lower mutation frequencies (less than 20-fold change) were separately plotted in the right panel using a smaller y axis scale. Data are means from two independent experiments at each time point.
Flanking sequence specificity for microsatellite mutation H Chung et al mutations occurring in real time. We first show the selectivity for ACVR2 exon 10 frameshift mutation over ACVR2 exon 3 in MMR deficiency using our model.
Indeed, as observed in CRC with MSI, only ACVR2 exon 10 frameshift mutation occurred, with none for ACVR2 exon 3 (M2 population) in both hMLH1 À/À and Figure S1) . MR plasmids were constructed by interrupting microsatellite sequences (A 8 to A 3 GA 4 ). MR IF and MR OF plasmids were used for positive and negative controls for EGFP expression, respectively. OF plasmids are the experimental plasmids. Six nucleotides (presented in italic) flanking ACVR2 exons 10 or 3 microsatellites on the 5 0 and 3 0 ends were replaced with the six nucleotides (presented in italic) flanking exons 3 or 10 microsatellites to construct ACVR2 exon 10-exon 3 F and ACVR2 exon 3-exon 10 F plasmids, respectively. The first nucleotides (T for exon 10 and G for exon 3) flanking 5 0 of the exon 10 or 3 microsatellites were not substituted to avoid generation of a new in-frame stop codon that would interrupt mutation analysis by EGFP expression. With these substituted sequences, MR IF and OF plasmids were constructed. Each substituted sequence had net four nucleotide changes (labeled in italic and bold letters) compared to WT sequence. ACVR2 exon 10 exon 3 F OF ACVR2 exon 10 OF MR ACVR2 exon 10 OF ACVR2 exon 3 exon 10 F OF ACVR2 exon 3 OF MR ACVR2 exon 3 OF Figure 4 Mutation analysis of cells containing substituted ACVR2 exons 10 or 3 sequences using flow cytometry. Non-fluorescent cells were sorted and exponentially grown for 14-35 days. At specific time points, cells were harvested and analyzed for EGFP expression using flow cytometry as described in Figure 1 . EGFP histograms of MR ACVR2 exon 10 OF, ACVR2 exon 10 OF, ACVR2 exon 10-exon 3 F OF, MR ACVR2 exon 3 OF, ACVR2 exon 3 OF, ACVR2 exon 3-exon 10 F OF cells in the hMLH1 À/À background at day 28 were shown as representatives of mutation analysis. Scaling of cell counts for each EGFP histogram is different.
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hMSH6
À/À cells, with neither sequence forming mutations in hMSH3 À/À cells. The ACVR2 exon 10 frameshift mutation rate is highest in hMLH1 À/À cells, which is 10-fold higher than the mutation rate observed for hMSH6 À/À cells. Thus, our human model is consistent with the selectivity observed for CRC, and as we previously described for our observations between mutation for TGFBR2 and ACVR2 (Chung et al., 2008) . Here, a clear selectivity exists for mutation of ACVR2 exon 10, whereas ACVR2 exon 3 is relatively protected from frameshift mutation even when DNA MMR function is absent. This dichotomy is remarkable between the two identical length coding microsatellites and perhaps even more remarkable when examining the microsatellites in our model out of the context of the tertiary DNA structure.
We swapped the 5 0 and 3 0 flanking nucleotides of the ACVR2 exon 10 microsatellite for the ones surrounding the ACVR2 exon 3 microsatellite, and vice versa. These constructs were transfected into hMLH1 À/À cells that show the highest mutation rate for the WT ACVR2 exon 10 microsatellite, and simulates sporadic MSI CRC that contain inactivated hMLH1 by promoter hypermethylation. In this study exon 3 flanking sequences that newly surround the ACVR2 exon 10 microsatellite slow the mutation rate by sixfold (Table 3) , and greatly diminish the accumulation of full mutant (M2) cells (Figure 5 ). In the opposing direction, exon 10 flanking sequences that newly surround ACVR2 exon 3 microsatellite allow the new completion of full mutant cells, a feat that the WT ACVR2 exon 3 flanking sequences do not allow at the ACVR2 exon 3 microsatellite. Thus, the sequence context of the ACVR2 coding microsatellites influences their mutation rates. Why this occurs is not clear. It has been previously suggested in yeast MMR that base pairs as far away as 15-18 nucleotides could affect mispair recognition, and that footprinting studies of yeast MSH2-MSH6 indicate that these proteins interact with DNA over a region of 25 nucleotides surrounding a mispair (Marsischky and Kolodner, 1999; Harrington and Kolodner, 2007) . Thus, the flanking sequences surrounding Abbreviations: ACVR2, activin type II receptor; EGFP, enhanced green fluorescent protein; IF, in frame of EGFP; OF, þ 1 bp out of frame of EGFP. Cells from the M1 and/or M2 populations of hMLH1 À/À ACVR2 exon 10 OF, ACVR2 exon 10-exon 3 F OF, ACVR2 exon 3 OF and ACVR2 exon 3-exon 10 F OF cells were sorted and cultured. DNA from each cell line was amplified by PCR, sub-cloned and all single cell clones were individually sequenced to assess for frameshift mutation at the coding microsatellite. Most DNA clones from the M2 population of hMLH1 À/À ACVR2 exon 10 OF and hMLH1 À/À ACVR2 exon 10-exon 3 F OF cells revealed À1 bp frameshift mutation (A 7 ), indicating full mutant (A 7 /T 7 ) formation. Note that hMLH1 À/À ACVR2 exon 10-exon 3 F OF cells showed a decrease in mutant M1 clones compared with hMLH1 À/À ACVR2 exon 10 OF cells, whereas hMLH1 À/À ACVR2 exon 3-exon 10 F OF cells showed an increase in mutant M1 clones compared with hMLH1 À/À ACVR2 exon 3 OF cells, indicating that these flanking sequences alter heteroduplex (A 8 /T 7 ) formation in the hMLH1 À/À background. Figure 5 Mutation frequencies of native and substituted ACVR2 exons 10 and 3 sequences in the hMLH1 À/À background. Nonfluorescent cells were analyzed for EGFP expression using flow cytometry at 14, 21, 28 and 35 days after being sorted and cultured, and EGFP analysis was performed at each day as shown in Figure 4 . Mutation frequency at each time point was determined as described in Figure 3 . In the M1 population, hMLH1 À/À ACVR2 exon 10 OF cells showed the highest mutation frequency followed by hMLH1 À/À ACVR2 exon 10-exon 3 F OF, hMLH1 À/À ACVR2 exon 3-exon 10 F OF and hMLH1 À/À ACVR2 exon 3 OF cells at all time points. The M2 population of hMLH1 À/À ACVR2 exon 10 OF cells revealed the highest mutation frequency over time compared with other cell lines. Significantly decreased mutation frequency was observed in the M2 population of hMLH1 À/À ACVR2 exon 10-exon 3 F OF cells compared with cells containing native ACVR2 exon 10 OF sequence. No full mutant M2 population was observed in hMLH1 À/À ACVR2 exon 3 cells whereas hMLH1 À/À ACVR2 exon 3-exon 10 F OF cells revealed its M2 population from day 28. Data are means from two independent experiments at each time point. À/À ACVR2 exon 3-exon 10 F OF cells.
Flanking sequence specificity for microsatellite mutation H Chung et al a DNA mismatch repairable target could affect the stability of the MMR protein-DNA interaction. This aspect could be tested by studying binding interactions between the human MMR proteins and DNA. Other hypotheses for affecting frameshift mutation include the strength of Watson-Crick hydrogen bonding around a mispair or IDLs, and the nature of the secondary structure of DNA. In our experiments, certainly the primary DNA structure helps dictate mutability of the ACVR2 microsatellites in the absence of DNA MMR. The establishment of our human model allowed us to clearly observe the occurrence of pass-through heteroduplexes (the M1 population), before full mutants (the M2 population). However, heteroduplex formation does not necessarily mean mutation is imminent, as either repair can occur, or the flanking sequences surrounding a microsatellite may prevent full mutation, and our data bear that out. Both ACVR2 exon 10 and 3 microsatellites developed an M1 heteroduplex population in hMLH1 À/À cells, but only the ACVR2 exon 10 microsatellite fully mutated. Cloned sequences from hMLH1 À/À ACVR2 exon 3 cells revealed a nearly even split between A 7 and A 8 sequences, very indicative of heteroduplex formation, and which occurred at a slow and steady rate but did not lead to a M2 population. When the flanking sequences from ACVR2 exon 10 microsatellite were placed around the ACVR2 exon 3 microsatellite, heteroduplex formation increased, and corresponded to the new observation of a M2 population. In addition, when the flanking sequences from ACVR2 exon 3 microsatellite were placed around the ACVR2 exon 10 microsatellite, heteroduplex formation slowed and corresponded to a reduction in the subsequent M2 population. Thus, the flanking sequences alter heteroduplex formation at microsatellite, which determines its ability to become fully frameshifted in the setting of defective MMR.
There are several genes containing coding microsatellites that can be potentially mutated in the setting of DNA MMR deficiency. However, analysis of tumors or cell lines indicates that the mutation frequencies vary widely between genes, even for coding microsatellites of the same length (Hempen et al., 2003; Jung et al., 2004) . In addition, some genes that show some degree of frameshift mutation have not fully shown that mutation has biological consequences. ACVR2, for example, has been shown to be frameshift mutated, and lose protein expression and tumor suppressor capability in CRC (Jung et al., 2004 (Jung et al., , 2007 . This study sheds a possible explanation of why certain genes may become frameshift mutated in the setting of defective MMR, whereas others do not, although it does not address subsequent biological functional consequences.
In summary, we showed frameshift mutation selectivity for the ACVR2 exon 10 over the ACVR2 exon 3 microsatellite in human colorectal cells with MMR deficiency in real time. We also showed that this selectivity for frameshift mutation within ACVR2 lies in part with the flanking nucleotides surrounding each microsatellite. Our study has implication for the occurrence of frameshift mutation at other microsatellite sequences and for how MMR deficiency drives frameshift mutation.
Materials and methods
Cloning of pIREShyg2-ACVR2 exon 10-EGFP and pIREShyg2-ACVR2 exon 3-EGFP plasmids Plasmids pIREShyg2-ACVR2 exon 10-EGFP, containing portions of exon 10 of hACVR2 were constructed previously (Chung et al., 2008) . Details of plasmid cloning were previously described (Chung et al., 2008) and the same cloning strategies were used to construct plasmids pIREShyg2-ACVR2 exon 3-EGFP containing portions of exon 3 of hACVR2. In brief, portions of exons 10 or 3 of ACVR2 (Table 1) were inserted immediately after the start codon of the EGFP gene, either IF or þ 1 bp OF in pIREShyg2-EGFP. For experimental plasmids, ACVR2 sequences were cloned þ 1 bp OF in pIREShyg2-EGFP and thus a À1 bp frameshift mutation at the coding microsatellite would allow EGFP expression. MR counterpart plasmids were constructed by interrupting the microsatellites (A 8 to A 3 GA 4 ) using a Quikchange II site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). The MR ACVR2 plasmids were placed OF ( þ 1bp) and IF to be used as negative and positive controls for EGFP expression, respectively.
Cloning of pIREShyg2-ACVR2 exon 10-exon 3 F-EGFP and pIREShyg2-ACVR2 exon 3-exon 10 F-EGFP plasmids Plasmids pIREShyg2-ACVR2 exon 10-exon 3 F OF and pIREShyg2-ACVR2 exon 3-exon 10 F OF (named as substituted plasmids) were constructed in which six nucleotides flanking ACVR2 exons 10 or 3 microsatellites on the 5' and 3' ends were replaced with the six nucleotides flanking ACVR2 exons 3 or 10 microsatellites by a site-directed mutagenesis, respectively (Table 1) . MR-IF plasmids for each substituted ACVR2 plasmid were constructed (Table 1) .
Cell lines, transfection and selection
The human colon cancer cell lines, HCT116 (hMLH1 À/À and hMSH3 À/À ), DLD-1 (hMSH6 À/À ) and HCT116 þ chr3 (hMLH1 restored but hMSH3 À/À ) were cultured as described previously (Chung et al., 2008) . Cells were transfected with different pIREShyg2-ACVR2-EGFP plasmids (described in Table 1 ) by using Nucleofector kits (Amaxa, Cologne, Germany) and stable cell lines were generated by hygromycin B (Invitrogen Corp., Carlsbad, CA, USA) selection. After selection, colonies from each cell line were initially pooled and cultured for mutation analysis. All stable cell lines were confirmed by DNA sequencing.
Mutation analysis by flow cytometry
The details of analysis of mutant cells using flow cytometry were previously described (Chung et al., 2008) . In brief, 5000 nonfluorescent cells expressing MR ACVR2 exon 10 OF, ACVR2 exon 10 OF, ACVR2 exon 10-exon 3 F OF, MR ACVR2 exon 3 OF, ACVR2 exon 3 OF or ACVR2 exon 3-exon 10 F OF were sorted into 24-well plates by FACS ARIA (Becton Dickinson, San Jose, CA, USA). During the analysis period, cultures were expanded as required to keep cells in exponential growth. Cells were trypsinized, washed in phosphate-buffered saline and resuspended in a total volume of 200 ml of phosphate-buffered saline, 0.5 mg/ml of propidium iodide and 3% bovine serum albumin. At specified time points, cell suspensions from two cultures were analyzed in parallel on a FACSCalibur (Becton Dickinson). The population with dim EGFP fluorescence was designated as M1, and the population with bright EGFP fluorescence was designated as M2. The counts of M1 and M2 cells were expressed as percentages of total live cell number.
PCR and DNA sequencing Total cellular DNA from stable cell lines as well as M1 and M2 cell populations were PCR-amplified by specific primers (Supplementary Figure S2) using a cloned Pfu DNA polymerase (Stratagene). The PCR products were used for DNA sequencing to identify stable cell lines and frameshift mutations at microsatellites of ACVR2 exons 10 and 3. In addition, we subcloned PCR-amplified ACVR2 DNA fragments from the M1 and M2 cell populations by using a TA cloning vector (Invitrogen Corp.) as per the manufacturer's protocol. DNA clones were then individually sequenced to determine the prevalence of mutated and WT ACVR2 microsatellite sequences.
Determination of À1 bp frameshift mutation rates of ACVR2 sequences in MMR-deficient cells Mutation rates were calculated using the 'method of the mean' developed by Luria and Delbruck (Luria and Delbruck, 1943) as described previously (Chung et al., 2008) .
Statistical analysis
Mutation frequencies and rates of cell lines were compared using t-test or one-way analysis of variance.
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